RxDoctor Payments Data

Elizabeth Stevenson, MD

Family Medicine · Birmingham, ALNPI 1710041777

Payments from drug & device makers

$202in general payments, 2019–2025

Across 13 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Agile Therapeutics, Inc.$33
  • Novo Nordisk$32
  • Pfizer$31
  • Kowa Pharmaceuticals America, Inc.$25
  • Axsome Therapeutics, Inc.$23
  • AbbVie$16
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$18893%
  • Education$147%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$202 in reported general payments places this provider in the 30th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$16,041
Medicare patients
59
Services billed
273

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$70,230
MounjaroTirzepatide42$50,206
JardianceEmpagliflozin35$43,672
EliquisApixaban34$31,153
TrulicityDulaglutide14$21,923
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$21,481
JanuviaSitagliptin Phosphate22$16,831
LinzessLinaclotide18$14,622
MyrbetriqMirabegron26$11,394
Spiriva RespimatTiotropium Bromide13$10,223
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen121$6,089
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen257$5,986
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$3,330
Lidocaine30$2,895
Gabapentin120$2,640

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$32$70,23053 claims
PfizerEliquis$31$31,15334 claims
GSKTrelegy Ellipta$12$21,48121 claims
AbbVieLinzess$16$14,62218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →